Novel three-drug regimen used to manage life-threatening developments.
In April 2021, a 42-year-old man reached out to Brian Hill, MD, PhD, for a second opinion after being diagnosed with hairy cell leukemia following a bone marrow biopsy at a healthcare facility in northwest Ohio.
“At the time of diagnosis, he was getting easily fatigued and couldn’t exercise,” explains Dr. Hill, Director of the Lymphoid Malignancies Program at Cleveland Clinic’s Taussig Cancer Institute. “He was experiencing a slow-moving progression of symptoms.”
Standard front-line therapy for hairy cell lymphoma –an indolent B-cell lymphoproliferative disease – is the chemotherapy medication cladribine. Dr. Hill recommended the patient begin the drug, typically administered daily for five days or via a continuous pump for seven days, but the situation quickly pivoted.
“When I met the patient for a virtual second opinion, I recommended he get vaccinated against SARS-CoV-2 before beginning treatment,” says Dr. Hill. “Within two weeks, however, he was hospitalized with COVID-19 pneumonia.”
Severe COVID-19 sends patient to ICU
The patient was admitted to his local hospital with fever and shortness of breath. He tested positive for COVID-19, and within a few days, his breathing became more labored. He was transferred to Cleveland Clinic’s main campus.
“His critical illness was exacerbated by neutropenia from his leukemia,” says Dr. Hill. “Once he was admitted to our ICU, he rapidly deteriorated.” Within a few days, the patient was intubated and put on mechanical ventilation. His oxygenation levels were so poor that he was placed in the prone position and underwent pharmacologic paralysis.”
Unfortunately, the patient’s severe COVID had severely compromised his immune system. “The only way to improve his neutrophil and white blood cell counts was to get the cancer cells out of the bone marrow,” says Dr. Hill. However, the oncology team quickly realized that the standard chemotherapy approach for hairy cell leukemia could prove detrimental.
“He would unlikely survive short-term worsening of his neutropenia caused by the administration of traditional chemotherapy with cladribine,” explains Dr. Hill.
Second-line treatment given through NG tube
After discussions with other oncologists and the patient’s critical care team, including pulmonology specialists, Dr. Hill began to administer vemurafenib, an FDA-approved tablet medication for treating melanoma that targets mutations in the BRAF gene.
Approximately 90% of hairy cell leukemia cases also have this same BRAF mutation, says Dr. Hill. Although vemurafenib is not as effective as cladribine for hairy cell leukemia, the drug has been proven to be an effective second-line treatment.
Twice a day for more than two weeks, caregivers crushed a 960-mg tablet of vemurafenib and administered it to the patient through a nasogastric tube. He also was treated with remdesivir for COVID-19.
Gradually, the patient’s neutrophil count recovered, his breathing improved and his fever abated. He was weaned off high levels of oxygen.
“His COVID finally turned the corner,” says Dr. Hill. “I give most of the credit to our medical ICU nurses, pharmacists and physicians whose great work kept him going through all this.”
Complications, more treatment and remission
During his time in the hospital, the patient suffered numerous complications, including bacteremia, ventilator-associated pneumonia. He also lost some function in his left hand from neurologic compression of his brachial plexus.
After two months in the medical ICU, the patient was transferred to a medical-surgical unit in mid-June and was later discharged from the hospital July 1. His treatment journey for hairy cell leukemia continued throughout.
“While vemurafenib is a good drug, it wasn’t good enough in his case,” says Dr. Hill. “He stopped making progress while in the hospital, so we gave him a 70% dose of cladribine.” Once discharged, the patient received a standard dosage of the monoclonal antibody medication rituximab, which was necessary due to ongoing cytopenias.
“It was a balancing act to provide enough treatment against the hairy cell leukemia, but not so much to set him back in terms of infectious complications,” explains Dr. Hill.
A year after his hairy cell leukemia diagnosis, the patient is in remission. His only residual medical deficit is impaired inflection of his left wrist, for which he is undergoing physical therapy. The patient is back at home with his family, including his wife and three children. He hopes to return to work within the next few months.
“For patients like this one with rare diseases who have atypical treatment courses, it’s important to think outside the box to get the best outcomes. Cleveland Clinic excels at that,” says Dr. Hill. “In this case, we could not wait for the patient to get better from COVID to treat the cancer. We had to address both at once.”

News
Breakthrough for long Covid patients who lost sense of smell
A breakthrough nasal surgery has restored the sense of smell for a dozen long Covid patients. Experts at University College London Hospitals NHS Foundation Trust successfully employed a technique typically used for correcting blocked nasal passages, [...]
Scientists Invent Plastic That Can Dissolve In Seawater In Just A Few Hours
Plastic waste and pollution in the sea have been among the most serious environmental problems for decades, causing immense damage to marine life and ecosystems. However, a breakthrough discovery may offer a game-changing solution. [...]
Muscles from the 3D printer
Swiss researchers have developed a method for printing artificial muscles out of silicone. In the future, these could be used on both humans and robots. Swiss researchers have succeeded in printing artificial muscles out [...]
Beneficial genetic changes observed in regular blood donors
Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences in the mutations that accumulate [...]
Shocking Amounts of Microplastics in the Brain – It Could Be Increasing Our Risk of Dementia
The brain has higher concentrations of plastic particles compared to other organs, with increased levels found in dementia patients. In a comprehensive commentary published in Brain Medicine, researchers highlight alarming new evidence of microplastic accumulation [...]
Baffling Scientists for Centuries: New Study Unravels Mystery of Static Electricity
ISTA physicists demonstrate that contact electrification depends on the contact history of materials. For centuries, static electricity has intrigued and perplexed scientists. Now, researchers from the Waitukaitis group at the Institute of Science and [...]
Tumor “Stickiness” – Scientists Develop Potential New Way To Predict Cancer’s Spread
UC San Diego researchers have developed a device that predicts breast cancer aggressiveness by measuring tumor cell adhesion. Weakly adherent cells indicate a higher risk of metastasis, especially in early-stage DCIS. This innovation could [...]
Scientists Just Watched Atoms Move for the First Time Using AI
Scientists have developed a groundbreaking AI-driven technique that reveals the hidden movements of nanoparticles, essential in materials science, pharmaceuticals, and electronics. By integrating artificial intelligence with electron microscopy, researchers can now visualize atomic-level changes that were [...]
Scientists Sound Alarm: “Safe” Antibiotic Has Led to an Almost Untreatable Superbug
A recent study reveals that an antibiotic used for liver disease patients may increase their risk of contracting a dangerous superbug. An international team of researchers has discovered that rifaximin, a commonly prescribed antibiotic [...]
Scientists Discover Natural Compound That Stops Cancer Progression
A discovery led by OHSU was made possible by years of study conducted by University of Portland undergraduates. Scientists have discovered a natural compound that can halt a key process involved in the progression [...]
Scientists Just Discovered an RNA That Repairs DNA Damage – And It’s a Game-Changer
Our DNA is constantly under threat — from cell division errors to external factors like sunlight and smoking. Fortunately, cells have intricate repair mechanisms to counteract this damage. Scientists have uncovered a surprising role played by [...]
What Scientists Just Discovered About COVID-19’s Hidden Death Toll
COVID-19 didn’t just claim lives directly—it reshaped mortality patterns worldwide. A major international study found that life expectancy plummeted across most of the 24 analyzed countries, with additional deaths from cardiovascular disease, substance abuse, and mental [...]
Self-Propelled Nanoparticles Improve Immunotherapy for Non-Invasive Bladder Cancer
A study led by Pohang University of Science and Technology (POSTECH) and the Institute for Bioengineering of Catalonia (IBEC) in South Korea details the creation of urea-powered nanomotors that enhance immunotherapy for bladder cancer. The nanomotors [...]
Scientists Develop New System That Produces Drinking Water From Thin Air
UT Austin researchers have developed a biodegradable, biomass-based hydrogel that efficiently extracts drinkable water from the air, offering a scalable, sustainable solution for water access in off-grid communities, emergency relief, and agriculture. Discarded food [...]
AI Unveils Hidden Nanoparticles – A Breakthrough in Early Disease Detection
Deep Nanometry (DNM) is an innovative technique combining high-speed optical detection with AI-driven noise reduction, allowing researchers to find rare nanoparticles like extracellular vesicles (EVs). Since EVs play a role in disease detection, DNM [...]
Inhalable nanoparticles could help treat chronic lung disease
Nanoparticles designed to release antibiotics deep inside the lungs reduced inflammation and improved lung function in mice with symptoms of chronic obstructive pulmonary disease By Grace Wade Delivering medication to the lungs with inhalable nanoparticles [...]